Insights Into Cannabis and Cannabinoids: Chemical Properties, Legal Perspectives, and Therapeutic Applications.

CED Clinical Relevanceย ย #100High Clinical Relevanceย ย Strong evidence or policy relevance with direct clinical implications.
๐Ÿ”ฌ Evidence Watchย ย |ย ย CED Clinic
PainEpilepsyPhytochemistryEvidence-BasedReview
Journal Chemistry & biodiversity
Study Type Randomized Trial
Population Human participants
Why This Matters

This comprehensive review synthesizes evidence across cannabis medicine’s core domainsโ€”phytochemistry, pharmacology, clinical applications, and regulatory frameworks. For clinicians entering cannabis medicine, it provides a structured foundation for understanding the complexity of whole-plant therapeutics beyond isolated cannabinoids.

Clinical Summary

This systematic review examines over 500 identified cannabis compounds including cannabinoids, terpenes, flavonoids, and alkaloids across therapeutic domains of chronic pain, epilepsy, oncology, psychiatry, and inflammation. The authors integrate historical use patterns, phytochemical analysis, clinical trial data, and regulatory perspectives to map current evidence. Notable limitations include acknowledgment of dosing uncertainties, long-term safety gaps, and standardization challenges that persist across cannabis medicine. The review emphasizes evidence gaps requiring randomized controlled trials for evidence-based practice advancement.

Dr. Caplan’s Take

โ€œThis review accurately captures both the therapeutic promise and clinical challenges I encounter dailyโ€”we have compelling mechanistic rationale and patient outcomes, yet dosing remains more art than science. The emphasis on standardization and rigorous trial design reflects the field’s maturation toward evidence-based practice.โ€

Clinical Perspective
๐Ÿง  Clinicians should use this as a reference framework for understanding cannabis complexity while maintaining realistic expectations about current evidence quality. Patients benefit from understanding that cannabis medicine involves multiple active compounds with varying effects, requiring individualized approaches rather than standardized protocols.

๐Ÿ’ฌ Join the Conversation

Have a question about how this applies to your situation? Ask Dr. Caplan โ†’

Want to discuss this topic with other patients and caregivers? Join the forum discussion โ†’

FAQ

This study item was assembled from normalized source metadata and pipeline scoring.






{“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “Insights Into Cannabis and Cannabinoids: Chemical Properties, Legal Perspectives, and Therapeutic Applications.”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41822997/”, “about”: “chemistry biodiversity randomized trial insights into”, “isPartOf”: “Chemistry & biodiversity”}